(Q39154580)

9 September 2017

title

Trimethoxy-resveratrol and piceatannol administered orally suppress and inhibit tumor formation and growth in prostate cancer xenografts (English)

1 reference

9 September 2017

1 reference

1 reference

Steven J Dias

1

1 reference

9 September 2017

Kun Li

2

1 reference

9 September 2017

Agnes M Rimando

3

1 reference

9 September 2017

Swati Dhar

4

1 reference

9 September 2017

Cassia S Mizuno

5

1 reference

9 September 2017

Alan D Penman

6

1 reference

9 September 2017

Anait S Levenson

7

1 reference

9 September 2017

publication date

8 May 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

73

1 reference

9 September 2017

issue

11

1 reference

9 September 2017

page(s)

1135-1146

1 reference

Alcohol consumption and risk of prostate cancer in middle-aged men

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Chemoprevention of prostate cancer through dietary agents: progress and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Control of prostate cell growth, DNA damage and repair and gene expression by resveratrol analogues, in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Mechanisms of apoptotic effects induced by resveratrol, dibenzoylmethane, and their analogues on human lung carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Piceatannol enhances TRAIL-induced apoptosis in human leukemia THP-1 cells through Sp1- and ERK-dependent DR5 up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Pro- and anticarcinogenic mechanisms of piceatannol are activated dose dependently in MCF-7 breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Distinct mechanisms of STAT phosphorylation via the interferon-alpha/beta receptor. Selective inhibition of STAT3 and STAT5 by piceatannol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Pharmacometrics of stilbenes: seguing towards the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Pterostilbene suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

The Use of 3,5,4'-Tri-O-acetylresveratrol as a Potential Pro-drug for Resveratrol Protects Mice from γ-Irradiation-Induced Death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Effects of resveratrol analogs on steroidogenesis and mitochondrial function in rat Leydig cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Dietary genistein inhibits metastasis of human prostate cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

MEK4 function, genistein treatment, and invasion of human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Synthesis and biological evaluation of an albumin-binding prodrug of doxorubicin that is cleaved by prostate-specific antigen (PSA) in a PSA-positive orthotopic prostate carcinoma model (LNCaP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Antitumor activity of 3,5,4'-trimethoxystilbene in COLO 205 cells and xenografts in SCID mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Anti-inflammatory action of pterostilbene is mediated through the p38 mitogen-activated protein kinase pathway in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Piceatannol, a catechol-type polyphenol, inhibits phorbol ester-induced NF-{kappa}B activation and cyclooxygenase-2 expression in human breast epithelial cells: cysteine 179 of IKK{beta} as a potential target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

The PCa Tumor Microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Advancing bioluminescence imaging technology for the evaluation of anticancer agents in the MDA-MB-435-HAL-Luc mammary fat pad and subrenal capsule tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Non-invasive detection of a small number of bioluminescent cancer cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: an in silico and biochemical approach targeting integrin αvβ3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Resveratrol analog (Z)-3,5,4'-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

In vitro and in vivo studies on stilbene analogs as potential treatment agents for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

A rapid HPLC method for the quantification of 3,5,4'-trimethoxy-trans-stilbene (TMS) in rat plasma and its application in pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Pharmacokinetics of selected stilbenes: rhapontigenin, piceatannol and pinosylvin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

Determination of stilbene derivatives in Burgundy red wines by ultra-high-pressure liquid chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22657

21 January 2018

Identifiers

DOI

10.1002/PROS.22657

1 reference

9 September 2017

1 reference